Seattle-based Proprio designed Paradigm to replace traditional surgical navigation technologies. Using an advanced approach, it avoids the pitfalls that pull attention away from the patient and disrupt workflows. Paradigm enables 3D, dynamic and segmental viewing of the anatomy.

The company won its first FDA clearance for Paradigm in 2023. This latest clearance includes intraoperative measurements. Proprio says it marks the first time in history that surgeons can measure success in real-time during surgery.

Paradigm can now share real-time progress against pre-operative plans with continuous, accurate measurements. It lets surgeons know when they have achieved their goals and uses real-time data to inform decisions during surgery. Proprio says it can save patients from several more revision surgeries and improve outcomes altogether.